Inhibikase Therapeutics to Report Fourth Quarter and Full-Year 2022 Financial Results on March 31, 2023 ...Middle East

BOSTON and ATLANTA, March 23, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkinson's-related disorders...

Hence then, the article about inhibikase therapeutics to report fourth quarter and full year 2022 financial results on march 31 2023 was published today ( Friday 24/03/2023 - 12:20 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Inhibikase Therapeutics to Report Fourth Quarter and Full-Year 2022 Financial Results on March 31, 2023 )

Also on site :

• Scammer posed as ‘well-known adult film star’ to defraud NFL and NBA players online from behind bars, feds say
• Video: What we know about Israel’s assault on southern Lebanon
• Sarah Michelle Gellar reveals who’s to blame for ‘Buffy’ reboot cancellation